Back to results
RecruitingPhase 1

Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI

NCT04332588

What is this trial?

Generating plain-language summary...

Am I eligible?

Generating eligibility summary...

What's involved?

Summarizing study design...

Where and how to apply

Primary location

The University of Alabama at Birmingham

Birmingham, Alabama, United States

Contact

Anna Sorace, PhD

205-934-3116asorace@uabmc.edu
View on ClinicalTrials.gov
Monitoring HER2+ Breast Cancer Neoadjuvant Treatment With Advanced PET/MRI — TrialFind